Soonkyu Chung1, John S Parks. 1. aDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, Nebraska, USA bDepartments of Internal Medicine/Molecular Medicine cBiochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: Adipose tissue is a critical endocrine and immunological organ that regulates systemic energy homeostasis. During the pathogenesis of obesity, adipocyte hypertrophy is accompanied by adipose tissue inflammation, impeding insulin sensitivity and endocrine function of adipose tissue and other tissues. Adipocyte cholesterol accumulates in proportion to triglyceride as adipocytes undergo hypertrophy. Recent studies suggest that dietary cholesterol contributes to increased adipocyte cholesterol. However, how dietary cholesterol accumulates in adipocytes and its metabolic consequences are poorly understood. This review summarizes recent advances in knowledge of adipocyte cholesterol balance and highlights the emerging role of dietary cholesterol in adipose tissue cholesterol balance, inflammation, and systemic energy metabolism. RECENT FINDINGS: Perturbation of cholesterol balance in adipocytes alters intracellular cholesterol distribution and modulates adipocyte insulin and proinflammatory signaling. Adipocyte cholesterol levels are maintained by a balance between dietary cholesterol uptake from triglyceride-enriched lipoproteins and cellular cholesterol efflux to HDL. Recent animal studies established a critical role for dietary cholesterol in promoting adipose tissue inflammation, thereby worsening obesity-mediated metabolic complications. SUMMARY: Recent studies identified high dietary cholesterol as a potentiator of adipose tissue inflammation and dysfunction. Reducing excessive dietary cholesterol intake is suggested as a simple, but novel, way to attenuate obesity-associated metabolic diseases.
PURPOSE OF REVIEW: Adipose tissue is a critical endocrine and immunological organ that regulates systemic energy homeostasis. During the pathogenesis of obesity, adipocyte hypertrophy is accompanied by adipose tissue inflammation, impeding insulin sensitivity and endocrine function of adipose tissue and other tissues. Adipocyte cholesterol accumulates in proportion to triglyceride as adipocytes undergo hypertrophy. Recent studies suggest that dietary cholesterol contributes to increased adipocyte cholesterol. However, how dietary cholesterol accumulates in adipocytes and its metabolic consequences are poorly understood. This review summarizes recent advances in knowledge of adipocyte cholesterol balance and highlights the emerging role of dietary cholesterol in adipose tissue cholesterol balance, inflammation, and systemic energy metabolism. RECENT FINDINGS: Perturbation of cholesterol balance in adipocytes alters intracellular cholesterol distribution and modulates adipocyte insulin and proinflammatory signaling. Adipocyte cholesterol levels are maintained by a balance between dietary cholesterol uptake from triglyceride-enriched lipoproteins and cellular cholesterol efflux to HDL. Recent animal studies established a critical role for dietary cholesterol in promoting adipose tissue inflammation, thereby worsening obesity-mediated metabolic complications. SUMMARY: Recent studies identified high dietary cholesterol as a potentiator of adipose tissue inflammation and dysfunction. Reducing excessive dietary cholesterol intake is suggested as a simple, but novel, way to attenuate obesity-associated metabolic diseases.
Authors: Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla Journal: Cell Date: 2014-06-05 Impact factor: 41.582
Authors: Eric D Labonté; Lisa M Camarota; Juan C Rojas; Ronald J Jandacek; Dean E Gilham; Joanna P Davies; Yiannis A Ioannou; Patrick Tso; David Y Hui; Philip N Howles Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-08-21 Impact factor: 4.052
Authors: Peitao Wu; Jee-Young Moon; Iyas Daghlas; Giulianini Franco; Bianca C Porneala; Fariba Ahmadizar; Tom G Richardson; Jonas L Isaksen; Georgy Hindy; Jie Yao; Colleen M Sitlani; Laura M Raffield; Lisa R Yanek; Mary F Feitosa; Rafael R C Cuadrat; Qibin Qi; M Arfan Ikram; Christina Ellervik; Ulrika Ericson; Mark O Goodarzi; Jennifer A Brody; Leslie Lange; Josep M Mercader; Dhananjay Vaidya; Ping An; Matthias B Schulze; Lluis Masana; Mohsen Ghanbari; Morten S Olesen; Jianwen Cai; Xiuqing Guo; James S Floyd; Susanne Jäger; Michael A Province; Rita R Kalyani; Bruce M Psaty; Marju Orho-Melander; Paul M Ridker; Jørgen K Kanters; Andre Uitterlinden; George Davey Smith; Dipender Gill; Robert C Kaplan; Maryam Kavousi; Sridharan Raghavan; Daniel I Chasman; Jerome I Rotter; James B Meigs; Jose C Florez; Josée Dupuis; Ching-Ti Liu; Jordi Merino Journal: Diabetes Care Date: 2022-01-01 Impact factor: 17.152
Authors: Edward B Neufeld; Masaki Sato; Scott M Gordon; Vinay Durbhakula; Nicolas Francone; Angel Aponte; Gizem Yilmaz; Denis Sviridov; Maureen Sampson; Jingrong Tang; Milton Pryor; Alan T Remaley Journal: Biology (Basel) Date: 2019-07-12
Authors: Ane Larrañaga-Vera; Ana Lamuedra; Sandra Pérez-Baos; Ivan Prieto-Potin; Leticia Peña; Gabriel Herrero-Beaumont; Raquel Largo Journal: Arthritis Res Ther Date: 2017-12-01 Impact factor: 5.156